Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SARS and Avian Flu -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (803)	5/12/2003 11:56:23 PM
From: Torben Noerup Nielsen	Respond to of 4232

When you are done playing with your hogs, go look at Fields. The statement is correct as far as it goes. Rhinovirus is largely eliminated by the innate immune response. The adaptive immune responnse is often weak and is not always required to clear the infection. It is known that reinfection is possible with the same serotype very soon after. It is also believed that repeated infections with a single serotype can build up immunity. Primarily IgA as I recall. This may or may not hold true for all serotypes. Note that there are at least three distinct cellular receptors used for infection by different serotypes.